Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
30983 | 130 | 27.3 | 64% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
701 | 12232 | RADIOIMMUNOTHERAPY//BISPECIFIC ANTIBODIES//EP CAM |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | GIRENTUXIMAB | Author keyword | 6 | 71% | 4% | 5 |
2 | G250 | Author keyword | 6 | 50% | 6% | 8 |
3 | MONOCLONAL ANTIBODY CG250 | Author keyword | 4 | 67% | 3% | 4 |
4 | CG250 | Author keyword | 4 | 75% | 2% | 3 |
5 | MONOCLONAL ANTIBODY G250 | Author keyword | 2 | 67% | 2% | 2 |
6 | ANTIFECTION | Author keyword | 1 | 50% | 1% | 1 |
7 | G250 MONOCLONAL ANTIBODY | Author keyword | 1 | 50% | 1% | 1 |
8 | RADIOIODINATED ANTIBODY | Author keyword | 1 | 50% | 1% | 1 |
9 | RENAL CALL | Author keyword | 1 | 50% | 1% | 1 |
10 | RENAL CELL CARCINOMA ANTIGEN | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GIRENTUXIMAB | 6 | 71% | 4% | 5 | Search GIRENTUXIMAB | Search GIRENTUXIMAB |
2 | G250 | 6 | 50% | 6% | 8 | Search G250 | Search G250 |
3 | MONOCLONAL ANTIBODY CG250 | 4 | 67% | 3% | 4 | Search MONOCLONAL+ANTIBODY+CG250 | Search MONOCLONAL+ANTIBODY+CG250 |
4 | CG250 | 4 | 75% | 2% | 3 | Search CG250 | Search CG250 |
5 | MONOCLONAL ANTIBODY G250 | 2 | 67% | 2% | 2 | Search MONOCLONAL+ANTIBODY+G250 | Search MONOCLONAL+ANTIBODY+G250 |
6 | ANTIFECTION | 1 | 50% | 1% | 1 | Search ANTIFECTION | Search ANTIFECTION |
7 | G250 MONOCLONAL ANTIBODY | 1 | 50% | 1% | 1 | Search G250+MONOCLONAL+ANTIBODY | Search G250+MONOCLONAL+ANTIBODY |
8 | RADIOIODINATED ANTIBODY | 1 | 50% | 1% | 1 | Search RADIOIODINATED+ANTIBODY | Search RADIOIODINATED+ANTIBODY |
9 | RENAL CALL | 1 | 50% | 1% | 1 | Search RENAL+CALL | Search RENAL+CALL |
10 | RENAL CELL CARCINOMA ANTIGEN | 1 | 50% | 1% | 1 | Search RENAL+CELL+CARCINOMA+ANTIGEN | Search RENAL+CELL+CARCINOMA+ANTIGEN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | G250 | 11 | 56% | 11% | 14 |
2 | NORMAL KIDNEY | 3 | 27% | 7% | 9 |
3 | MONOCLONAL ANTIBODY G250 | 2 | 17% | 7% | 9 |
4 | GIRENTUXIMAB | 1 | 100% | 2% | 2 |
5 | MONOCLONAL ANTIBODY CG250 | 1 | 50% | 2% | 2 |
6 | RADIOLABELS | 1 | 25% | 2% | 3 |
7 | ANTIFECTION | 1 | 50% | 1% | 1 |
8 | TUMOR ANTIGEN EXPRESSION | 1 | 50% | 1% | 1 |
9 | ANTIGEN G250 | 0 | 15% | 2% | 2 |
10 | BRAIN ENOLASE | 0 | 17% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Application of Monoclonal Antibody G250 Recognizing Carbonic Anhydrase IX in Renal Cell Carcinoma | 2013 | 14 | 60 | 33% |
Molecular imaging and carbonic anhydrase IX-targeted radioimmunotherapy in clear cell renal cell carcinoma | 2013 | 8 | 55 | 22% |
Renal cell cancer and positron emission tomography - an evolving diagnostic and therapeutic relationship | 2007 | 1 | 45 | 16% |
RENAL-CELL CARCINOMA - SURVEY OF CLINICAL ASPECTS | 1983 | 0 | 3 | 33% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NUCL MED 565 | 0 | 15% | 1.5% | 2 |
2 | MOL PHARMACOL THER Y SERV | 0 | 25% | 0.8% | 1 |
3 | IMMUNOALLERGY UNIT | 0 | 14% | 0.8% | 1 |
4 | HITACHI INC | 0 | 100% | 0.8% | 1 |
5 | IRCCS POLYTECH | 0 | 100% | 0.8% | 1 |
6 | NUCL MED 756 | 0 | 100% | 0.8% | 1 |
7 | PATHOL WASSENAARSEWEG 62 POB 9603 | 0 | 100% | 0.8% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000167957 | RADIOIMMUNOTHERAPY//PRETARGETING//Y 90 IBRITUMOMAB TIUXETAN |
2 | 0.0000158815 | CHIM BIOINORGAN//CARBONIC ANHYDRASE//SEZ SCI FARMACEUT |
3 | 0.0000129716 | RENAL CELL//RADICAL NEPHRECTOMY//FUHRMAN GRADING |
4 | 0.0000122714 | FP3//HOLLOW FIBRE ASSAY//AFFILIATED ZHUJI HOSP |
5 | 0.0000121538 | COMPUTER BASED CLASSIFICATION//BLADDER WASHING//TRANSITIONAL CELL BLADDER CANCER |
6 | 0.0000104130 | INTIMA TO MEDIA RATIO//EPIDEMIOL HLTH BEHAV SOC//BIOL DOSE SECT |
7 | 0.0000101519 | ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS//RADIOIMMUNOGUIDED SURGERY//IMMUNOSCINTIGRAPHY |
8 | 0.0000097020 | C 11 CHOLINE PET CT//C 11 CHOLINE//CHOLINE PET |
9 | 0.0000095435 | RENAL ONCOCYTOMA//CHROMOPHOBE RENAL CELL CARCINOMA//COLLECTING DUCT CARCINOMA |
10 | 0.0000091067 | AFFIBODY MOLECULE//AFFIBODY MOLECULES//AFFIBODY |